Evaluation of the Value of Cerebral Perfusion Scintigraphy in the Study of Post-stroke Fatigability
NCT ID: NCT03543280
Last Updated: 2018-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
32 participants
OBSERVATIONAL
2018-02-23
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Neuropsychological tests are almost always done at 3 months. Fatigue is studied: PSF scale at 3 months, 6 months and 2 years. Research needs to be continued in this area because the pathophysiology remains unknown and the symptoms are disabling for patients. Using cerebral perfusion imaging would bring elements of understanding of this mechanism and ultimately improve the management of patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
NCT05865795
Brain PERfusion Evaluation by Contrast-Enhanced UltraSound
NCT05893407
Hypoperfusion-hypodensity Mismatch for the Identification of Patients With Stroke Within 4.5 Hours
NCT04277728
Perfusion Imaging Score to Predict Delayed Cerebral Ischemia
NCT07030985
Predictive Value for Stroke
NCT00451529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission for transient ischemic attack, stroke, dissection, TVC
* RANKIN less than or equal to 2
* Neuropsychological tests at +3 months: MoCA\> 26 (to eliminate cognitive deteriorations too important for the good realization of the battery)
* Absence of psychiatric history
* Absence of psychotropic medication
* No history of stroke
* No complaint of pre-stroke fatigue
* Having signed the consent form
Exclusion Criteria
* Subject under the protection of justice
* Subject under guardianship or curatorship
* Refusal of the patient to participate in the study
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Biophysique et de Médecine Nucléaire
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6787
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.